State Regulatory Committee
The primary goal of the SRC is to assist state cannabis commissions in adopting “best practice” public health regulations. The SRC will consist of a physician representative from each state where cannabis is or will soon become legal for adult use. By working together across different jurisdictions, we hope to develop and endorse recommendations, guidelines, and white papers that define optimal public health-oriented policies for the production, testing, labeling, distribution, and sale of cannabis.
Bryon Adinoff MD, Colorado, is an addiction psychiatrist and academician. He received his medical degree from Michigan State University, completed residency training in psychiatry at Tulane University, and did a postdoctoral fellowship in the Laboratory of Clinical Studies at the National Institute on Alcohol Abuse and Alcoholism. He has published over 160 articles and chapters on the biology and treatment of addiction and is Editor-in-Chief of The American Journal of Drug and Alcohol Abuse. Dr. Adinoff’s work has been funded by the Department of Veterans Affairs, the National Institutes on Drug Abuse (NIDA), Alcohol Abuse and Alcoholism (NIAAA), and Arthritis and Musculoskeletal and Skin Diseases (NIAMS). He has been recognized as a Distinguished Fellow in the American Academy of Addiction Psychiatry and is a Fellow in the American College of Neuropsychopharmacology. His focus is gradually evolving from the consequences of substance use itself to the consequences of the drug war. His commitment to the goals of DFCR arise from his desire to assure that the harsh, punitive approach towards cannabis use is replaced by a regulatory system that protects both the individual and society.
Malik Burnett MD, MBA, Washington D.C., is a physician advocate, drug policy expert, and civil rights reformer, who organized the campaign to legalize marijuana possession in Washington, DC. Although Colorado and Washington state have received global attention for legalizing recreational marijuana sales, Washington DC is the first jurisdiction in the nation to undertake a drug policy reform agenda in an explicit racial justice framework.
He is currently a resident physician in the Johns Hopkins General Preventive Medicine program, where he is developing the empirical data surrounding clinical outcomes for medical marijuana and analyzing the public health implications of current drug policy with the goal shifting the framework of US drug policy from one based on criminal justice towards a policy focused on health and human rights. Before coming to Johns Hopkins, Dr. Burnett was a policy manager in the Office of National Affairs for the Drug Policy Alliance, where, in addition to legalizing marijuana possession, he assisted with passage of a Good Samaritan law and other harm reduction policies.
Dr. Burnett completed his internship in general surgery at the University of Massachusetts Medical Center, where he also worked with the Massachusetts Department of Public Health to help define physician involvement with the state's nascent medical marijuana program. He previously served on the Duke Board of Trustees and is a current advisory board member to Marijuana Majority. He also currently serves as the Criminal Justice Co-Chair for the DC Branch of the NAACP. He has appeared on numerous local and national television and print media publications discussing drug policy including CNN, Fox News, CBS, NBC, VICE News, NY Times, Washington Post, Huffington Post, and Rolling Stone.
- Sunil Aggarwal, MD, PhD - Washington
- Hugh Blumenfeld, MD, PhD - Connecticut
- Janice Marie Vaughn Knox, MD - Oregon
- Donald O. Lyman, MD, DTPH - California
- Brian Muraresku, JD (ex officio)
- David L. Nathan, MD, DFAPA (Founder, Board President) - New Jersey
- Sue Sisley, MD - Arizona/Nevada
- Dustin Sulak D.O. - Maine
- Jordan Tishler, MD (Board Treasurer) - Massachusetts
- Genester Wilson-King, MD, FACOG - Florida
Sunil Aggarwal, MD, PhD, Washington serves as an Integrative Pain, Palliative Care, and Rehabilitation Physician in private practice at SageMED (Bellevue, WA) and as an on-call MultiCare Physician and Associate Medical Director of MultiCare Hospice (Tacoma, WA). He is board-certified in Physical Medicine and Rehabilitation and Hospice and Palliative Medicine. He has Affiliated Faculty Appointments with the MultiCare Institute of Research and Innovation, the National Family Medicine Residency, University of Washington Geography Department, and University of Washington School of Medicine.
He completed his Internship at Virginia Mason, Residency at NYU, and Clinical Fellowship at the NIH Clinical Center. He has over two dozen peer-reviewed publications which have been cited 446 times (Google Scholar). Sunil’s dissertation project, “The medical geography of cannabinoid botanicals in Washington state: Access, delivery, and distress”, received NIH first-issued Certificates of Confidentiality. He led the AMA to call in 2009 for a review of marijuana scheduling. His review article: “Cannabinergic Pain Medicine: A Concise Clinical Primer and Survey of Randomized Controlled Trial Results” was featured on the cover of the February 2013 issue of the Clinical Journal of Pain, the 8th top-ranked journal in Anesthesiology, as per Web of Science. A poster based on the findings of this article received a poster award at the 2013 American Academy of Hospice and Palliative Medicine Annual Assembly. He has helped develop accredited clinician educational modules based on this work. He also wrote an entry “Cannabis for Symptom Control” for Fast Facts and Concepts, a standard reference that provides concise, practical, peer-reviewed and evidence-based summaries on key palliative care topics important to clinicians and trainees caring for patients facing serious
illness. They are cross-published in the Journal of Palliative Medicine, and are indexed by Medline. He recently co-wrote a chapter in a first-of- its-kind collection, The Routledge Handbook of the Philosophy of Pain, on Pain and Controlled Pain-Relieving Substances in which he described the faux health science logics of euphoria pathologization, asocial addictionology, and pharmacologicalism.
Hugh Blumenfeld, MD, PhD, Connecticut, has worked as a family physician in Hartford, CT since 2010. He maintains a full scope of practice that includes both outpatient primary care and hospitalist care, with privileges in prenatal care and obstetrics. He also serves as Medical Director for a non-profit hospice care company. Dr. Blumenfeld completed his medical training at University of Connecticut and afterward joined the faculty. As Assistant Professor of Family Medicine, he teaches medical students and helps train residents at UConn's Family Medicine Residency Program. His areas of academic interest include behavioral medicine, bioethics and evidence-based medicine. Before embarking on a career in medicine, Dr. Blumenfeld was a professor of English, having earned a PhD in Poetics at New York University with prior degrees from University of Chicago and Massachusetts Institute of Technology. His interest in cannabis regulation stems from his training in its many medicinal uses and his work in a community disproportionately impacted by its criminalization.
Janice Marie Vaughn Knox, MD, Oregon, has more than 35 years in the practice of medicine. She is a graduate of the University of California at Berkeley and the University of Washington School of Medicine. She is a wife, mother, best selling author and Board Certified Anesthesiologist.Dr. Janice Knox is a certified American Academy of Cannabinoid Medicine Specialist and Oregon representative for Doctors for Cannabis regulation. Dr. Knox is a cofounder of the American Cannabinoid Clinics along with her physician husband, Dr. David and 2 daughters Dr. Rachel Knox and Dr. Jessica Knox.Over her years in the operating room, Dr. Janice witnessed the increased use of life threatening pain medications and unnecessary medical interventions that yield low success rates while patients continued to get sicker. This awareness motivated Dr. Janice to become an expert in cannabis and the fields Cannabis Therapeutics and Endocannabinology. Dr. Janice passionately believes in cannabis as a medicine. Just as passionately she believes that education about cannabis along with safe, quality and tested products will help to remove the negative stigma that continues to prevent cannabis from becoming mainstream medicine. This will change when regulations are in place that will set standards for growing, testing, producing and packaging cannabis as a medicine.
Donald O. Lyman, MD, DTPH, California, received his BA in chemistry from the University of Pennsylvania (1964), his MD from Yale University (1968) and DTPH from the London School of Hygiene and Tropical Medicine (1974). He did his residency training at the Universities of Miami (Florida) and the University of California, San Diego. Dr. Lyman served in the U.S. Public Health Service as an EIS (Epidemic Intelligence Service) officer (1970-74), and as senior disease control officer for New York State (1974-78) and California (1978-2012). He was President of the National Association of Chronic Disease Directors (NACDD; 2010), was President of the American Cancer Society, California Division (2003-2004) and was secretary of the American Heart Association, Western States Affiliate (2008-2009). In California, he launched the tobacco control effort which brought a 50% reduction in adult smoking prevalence, 80% reduction on tobacco consumption and concurrent marked reductions in heart disease, stroke and tobacco related cancers (35% reduction in lung cancer). In his work with the California Medical Association (CMA), he authored its landmark white paper “Cannabis and the Regulatory Void” (2011) which led to the statewide ballot initiative “Adult Use of Marijuana Act” (Proposition 64, 2016) of which he was one-of-two chief legal “proponents” and which passed with a 57% vote. He is now Chair of CMA’s Council on Science and Public Health which oversees progress in implementing this new statute.
Dustin Sulak D.O., Maine, is a general practice osteopath with a focus in integrative medicine and and cannabinoid medicine. His clinical practice focuses on treating refractory conditions in adults and children. Dr. Sulak hold bachelor degrees in Biology and Nutrition Science from Indiana University, his doctorate in osteopathic medicine from Midwestern University, and completed his internship at Maine-Dartmouth Family Medicine Residency. Dr. Sulak is the founder of Integr8 Health, a medical practice in Maine that follows over 8,000 patients using medical cannabis, Healer.com, a medical cannabis patient education resource, and Cannabis Expertise, a continuing medical education curriculum. He sits on the board of directors of the Society of Cannabis Clinicians and has lectured to healthcare providers internationally on the science and clinical applications of cannabis.
Genester Wilson-King, MD FACOG, Florida, is a Board Certified Obstetrician and Gynecologist, a Fellow of the American College of Obstetrics and Gynecologists, and an established physician with more than 25 years of clinical experience. She is the Founder and Medical Director of Victory Rejuvenation Center, which combines her obstetrical and gynecological experience with age and lifestyle management through nutrition, exercise, plant based medicine and supplement use, medical cannabis education and consultant, and hormone balancing. She is a member of the Board of Directors for the Society of Cannabis Clinicians, the state of Florida representative for Doctors For Cannabis Regulation, provides expert opinions for cannabis legal cases, Medical Director of Remeny Wellness MMTC, and is a nationally recognized age management speaker and cannabis educator/speaker. Widely lauded by colleagues and patients alike, her quality of care, professionalism, medical integrity, open-mindedness with strong interpersonal skills and a deep-seated commitment to the art of medicine distinguish her.